Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice.
about
Viral bacterial artificial chromosomes: generation, mutagenesis, and removal of mini-F sequencesThe evolution of poxvirus vaccinesGeneration of a complete single-gene knockout bacterial artificial chromosome library of cowpox virus and identification of its essential genesModified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseasesViral vector-based influenza vaccines.Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral ProteinsA systemic macrophage response is required to contain a peripheral poxvirus infectionRedundancy complicates the definition of essential genes for vaccinia virus.Recombinant modified vaccinia virus Ankara generating excess early double-stranded RNA transiently activates protein kinase R and triggers enhanced innate immune responses.Smallpox vaccines: targets of protective immunity.A novel naturally occurring tandem promoter in modified vaccinia virus ankara drives very early gene expression and potent immune responsesDeletion of major nonessential genomic regions in the vaccinia virus Lister strain enhances attenuation without altering vaccine efficacy in mice.Identification of 10 cowpox virus proteins that are necessary for induction of hemorrhagic lesions (red pocks) on chorioallantoic membranes.Measurement of antibody responses to Modified Vaccinia virus Ankara (MVA) and Dryvax(®) using proteome microarrays and development of recombinant protein ELISAsThe vaccinia virus O1 protein is required for sustained activation of extracellular signal-regulated kinase 1/2 and promotes viral virulence.Attenuation of monkeypox virus by deletion of genomic regionsAttenuation and immunogenicity of host-range extended modified vaccinia virus Ankara recombinants.The strategic use of novel smallpox vaccines in the post-eradication world.Environmental risk assessment of clinical trials involving modified vaccinia virus Ankara (MVA)-based vectors.Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?CRISPR/Cas9-Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development.
P2860
Q26860414-A42A2ADD-C3B4-42B0-9F40-7EB61592B34AQ26995905-D4743EC7-6154-49F1-A746-56C3DA734249Q28659589-678DF372-96ED-4A38-B226-C70264FBC2B8Q30209342-DDB62013-77F5-4F48-8975-1EE5B55D1B0BQ30390938-3CAB204C-1EBF-4E97-AF65-F7997C6242E1Q33770634-4E5FEA85-DAED-4C1D-B24E-0C4C37C8A040Q33834887-E9CD808F-1917-49FF-902B-B89765733427Q34490252-42D5F558-9445-42C7-99D7-FDCF12B7AB8AQ34594898-6DEC93CD-43B4-401D-97C3-0DB0F30C81B7Q34780607-50A551E8-6C56-4EC4-9323-EE5647AB916AQ34952043-935A9031-B38B-40DF-B1ED-706D2686847BQ35076706-DAC0C90E-5AC5-4852-9080-422E462F945EQ35172311-8552BC05-1B69-4F52-8A3D-F3318ED6EFA1Q35634159-384E806E-1348-4DE6-8618-BB51AFEC9068Q35826480-CE6676D6-0D84-43C3-9267-0FBF1F2AFF7CQ36483811-FD70B144-632A-4A49-9D87-B1F02E40F7F1Q37209483-9BE3C660-4C74-40E5-831B-1E2130E57155Q37909421-03A3DF0D-8553-4B4A-BC3C-C26ABFFC4C65Q38176419-AFF967FA-C996-4D55-8230-093A91D8F17AQ38741327-EE1065D3-DC9A-4480-A9EB-547D7F768C7AQ45325213-90CDCFB8-E1CF-4C76-8838-25C3B0B9899DQ47549689-43310674-EE91-401C-97E0-C4D54BB059EF
P2860
Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Introduction of the six major ...... e in cell culture and in mice.
@ast
Introduction of the six major ...... e in cell culture and in mice.
@en
Introduction of the six major genomic deletions of modified vaccinia virus Ankara
@nl
type
label
Introduction of the six major ...... e in cell culture and in mice.
@ast
Introduction of the six major ...... e in cell culture and in mice.
@en
Introduction of the six major genomic deletions of modified vaccinia virus Ankara
@nl
prefLabel
Introduction of the six major ...... e in cell culture and in mice.
@ast
Introduction of the six major ...... e in cell culture and in mice.
@en
Introduction of the six major genomic deletions of modified vaccinia virus Ankara
@nl
P2093
P2860
P356
P1433
P1476
Introduction of the six major ...... e in cell culture and in mice.
@en
P2093
Christine Meisinger-Henschel
Heike Kachelriess
Jürgen Hausmann
Karen Baur
Mark Suter
Markus Wagner
Michael Wolferstätter
Michaela Späth
Paul Chaplin
Susanne Lukassen
P2860
P304
P356
10.1128/JVI.00756-10
P407
P577
2010-07-28T00:00:00Z